Q1 19 results | RGLS Message Board Posts

Regulus Therapeutics Inc.

  RGLS website

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  553 of 563  at  5/10/2019 5:32:49 AM  by

Dendrimer


Q1 19 results

 "I am proud of the significant progress we have made thus far in 2019 to reposition Regulus with a strengthened balance sheet, restructured term loan and reduced operating cash burn rate.  Importantly, the team has maintained its focus in its engagement with FDA, and we look forward to resuming our ADPKD clinical program pending FDA alignment.  We believe the total potential proceeds from the recent financing, highlighted by a strong investor syndicate, provides sufficient capital to fund planned activities into the second half of 2021," said Jay Hagan, CEO of Regulus. "We look forward to providing future updates on our ADPKD program, as well as further advancements from our promising preclinical pipeline"

They need to get RGLS4326 back into the clinic by the end of the year in order to access the second tranche of the financing which will see them through to 2021. Given that they submitted 13 week tox data back in January, and are still working with the FDA, I hope the delay is because the FDA has asked for 26 week data (which should already be available) and that the ADPKD will get back in the clinic the the second half of this year.

The other benefit of now having cash through 2021, is that they are in a less desperate negotiating position for the GBM and NASH programmes that they have said they want to partner.  So hopefully we'll have some positive news on these programmes in the coming months too.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 80
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...